Rigel Pharmaceuticals Inc (RIGL)
0.9844
-0.04
(-3.49%)
USD |
NASDAQ |
May 10, 16:00
0.9844
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash and Short Term Investments (Quarterly): 56.93M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 56.93M |
| September 30, 2023 | 62.35M |
| June 30, 2023 | 64.36M |
| March 31, 2023 | 58.66M |
| December 31, 2022 | 58.21M |
| September 30, 2022 | 81.64M |
| June 30, 2022 | 89.17M |
| March 31, 2022 | 107.52M |
| December 31, 2021 | 124.97M |
| September 30, 2021 | 143.15M |
| June 30, 2021 | 153.39M |
| March 31, 2021 | 39.34M |
| December 31, 2020 | 57.33M |
| September 30, 2020 | 72.81M |
| June 30, 2020 | 92.50M |
| March 31, 2020 | 95.93M |
| December 31, 2019 | 98.08M |
| September 30, 2019 | 107.48M |
| June 30, 2019 | 112.38M |
| March 31, 2019 | 127.92M |
| December 31, 2018 | 128.54M |
| September 30, 2018 | 115.64M |
| June 30, 2018 | 134.99M |
| March 31, 2018 | 94.30M |
| December 31, 2017 | 115.75M |
| Date | Value |
|---|---|
| September 30, 2017 | 68.08M |
| June 30, 2017 | 82.30M |
| March 31, 2017 | 98.14M |
| December 31, 2016 | 74.77M |
| September 30, 2016 | 85.26M |
| June 30, 2016 | 94.94M |
| March 31, 2016 | 103.63M |
| December 31, 2015 | 126.28M |
| September 30, 2015 | 134.35M |
| June 30, 2015 | 143.94M |
| March 31, 2015 | 161.16M |
| December 31, 2014 | 143.16M |
| September 30, 2014 | 157.67M |
| June 30, 2014 | 176.03M |
| March 31, 2014 | 195.38M |
| December 31, 2013 | 211.98M |
| September 30, 2013 | 230.88M |
| June 30, 2013 | 251.64M |
| March 31, 2013 | 272.45M |
| December 31, 2012 | 298.24M |
| September 30, 2012 | 183.90M |
| June 30, 2012 | 202.64M |
| March 31, 2012 | 223.30M |
| December 31, 2011 | 247.64M |
| September 30, 2011 | 265.68M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
39.34M
Minimum
Mar 2021
153.39M
Maximum
Jun 2021
88.22M
Average
89.17M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Nektar Therapeutics | 303.62M |
| Avid Bioservices Inc | 30.71M |
| Stereotaxis Inc | 19.82M |
| Cara Therapeutics Inc | 100.76M |
| Ardelyx Inc | 202.58M |